ViTToria Biotherapeutics
Philadelphia, PA
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
vittoriabio.comCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $25,000,000
Headquarters Location
- Philadelphia, PA
Public
- No
Acquired
- No
CEO
Nicholas Siciliano
Founders
- Marco RuellaNicholas Siciliano
Company Collections
These are collections ViTToria Biotherapeutics is a part of. Click on the collection name to view similar companies.